What is new?
◯◯◯◯◯◯◯◯◯◯
News and
Content
stay up to date with our
latest news & publications

Fixing the engineering problem

Article

Imagine testing a cancer treatment on a patient’s tumor before giving it to the patient. We grow living tumors from patient samples, test drug responses and use the results to teach our AI which treatments could work - and for whom. Test the tumor. Predict response. Design smarter trials.

READ MORE

Why cancer AI needs a lab in the loop

Article

Imagine testing a cancer treatment on a patient’s tumor before giving it to the patient. We grow living tumors from patient samples, test drug responses and use the results to teach our AI which treatments could work - and for whom. Test the tumor. Predict response. Design smarter trials.

READ MORE

Redefining precision medicine

ARTICLE

Pathway Bio is building a functional precision medicine platform to predict which therapies will be most effective for individual patients. We spoke to its CEO and co-founder Bobby Kaura about his experiences of launching the start-up and the KQ Labs entrepreneurial programme.

READ MORE

Evaluation of tumor response

PUBLICATION

Only 20 percent of renal and bladder cancer patients will show a signicant response to immune checkpoint inhibitor (ICI) therapy, and no test currently available accurately predicts ICI response.

READ MORE

Comprehensive Genomic Analysis

PUBLICATION

To select optimal therapies based on the detection of actionable genomic alterations in tumor samples is a major challenge in precision medicine.

READ MORE